MAPT and early-onset autosomal dominant Alzheimer disease: Impaired glucose metabolism, such as type 2 diabetes and insulin resistance, may lead to impaired neuronal insulin signaling, neuroinflammation, oxidative stress, resulting in amyloid-β accumulation, tau hyper-phosphorylation and subsequent cognitive decline and Alzheimer's disease [12, 13].